openPR Logo
Press release

Pruritus Therapeutics Market: Global Snapshot by 2020

01-25-2017 07:07 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Syndicate Market Research

Pruritus is a chronic itching condition caused due to dermatological disease including atopic dermatitis, contact dermatitis, mycoses, chickenpox etc. Growing prevalence of diseases like atopic dermatitis, allergic contact dermatitis and urticaria around the world is expected to drive pruritus therapeutics market.

Increasing global prevalence of atopic dermatitis, allergic contact dermatitis, and urticaria is expected to drive the pruritus therapeutics market over the forecast period. Development of new and a strong pipeline for pruritus therapeutics attributes to the rising demand of pruritus therapeutics over the forecast period. However, lack of awareness of the root cause of pruritus and a universally accepted therapy for pruritus is expected to hamper the growth of pruritus therapeutics industry.

Get a copy of free Sample Report @ http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=61517

The report provides a comprehensive view on the pruritus therapeutics; we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the pruritus therapeutics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, and general attractiveness. The market size and forecasts in terms of revenue (USD million) for the period 2015 to 2020, considering 2014 as the base year, have been provided for this segment of the report.

The report segments the pruritus therapeutics market on the basis of type, disease type, and geography. Corticosteroids, antihistamines, local anesthetics, counterirritants, immunosuppressant, calcineurin inhibitors and others are major product segment of pruritus therapeutics market analyzed in this study. Corticosteroid was the leading product segment of pruritus therapeutics market in 2014 in terms of revenue. On the basis of the type of disease, pruritus therapeutics is segmented into atopic dermatitis, allergic contact dermatitis, urticaria and others. The global demand for pruritus therapeutics increases due to the high prevalence of dermatological disorders.

Get in-depth TOC (Table of Contents) with Tables and Figures @ https://goo.gl/aD9iyK

Major regional segments analyzed in this study include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, further bifurcation of the region on the country level, which includes U.S., Germany, UK, France, China, Japan, and India. The invention of new products and the existence of favorable government initiatives are expected to show lucrative growth in North America over the forecast period. Due to which North America dominated the overall industry in terms of revenue in 2014.

The key players of the pruritus therapeutics market include Pfizer, Tai Guk Pharmaceutical Company, Cara Therapeutics, Sanofi, Actavis, Trevi Therapeutics, Ocera Therapeutics Inc. and NeRRe Therapeutics.

Inquire more before buying this report @ https://goo.gl/cLaQmX

The report segments the global pruritus therapeutics market into:

Global Pruritus Therapeutics Market: Product Segment Analysis

Corticosteroids
Antihistamines
Local Anesthetics
Counterirritants
Immunosuppressant
Calcineurin Inhibitors
Others
Global Pruritus Therapeutics Market: Disease Type Segment Analysis

Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Others
Global Pruritus Therapeutics Market: Regional Segment Analysis

North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East & Africa

Browse detail report @ http://www.syndicatemarketresearch.com/market-analysis/pruritus-therapeutics-market-global-industry-perspective-comprehensive-analysis.html

About Us:
Syndicate Market Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Syndicate Market Research cover more than 30 industries including energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with the one-stop solution for all the research requirements.

Contact Us:
Joel John
3422 SW 15 Street, Suite #8138
Deerfield Beach, Florida 33442
United States
Toll Free: +1-855-465-4651 (USA-CANADA)
Tel: +1-386-310-3803
Email: sales@syndicatemarketresearch.com
Website: http://www.syndicatemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pruritus Therapeutics Market: Global Snapshot by 2020 here

News-ID: 421319 • Views: 451

More Releases from Syndicate Market Research

Global Jet Engines Market Statastical Data Analysis by Market Cap with COVID Pan …
"Global Jet Engines market 2021- 2027 Report" has been highlighted by Syndicate Market Research Organization and has Extensive data on factors that will amplify the growth of Jet Engines Market over the upcoming seven years. It additionally has an In-depth analysis of the industry’s competitive landscape, restraints, detailed information about different drivers, and opportunities. It Furnishes detailed data on the variables that will limit the development of Jet Engines
Global Telecom Software Professional Services Market Company Share Analysis Mode …
The Telecom Software Professional Services Market Report provides an in-depth analysis of the global Telecom Software Professional Services market, comprising the overall market synopsis, classifications, applications, definitions, and industry chain structure. The report will be offering a significant insight while shedding light on the key players [Amdocs, Ericsson, HPE, Huawei] actively participating and contributing to the growth of the global Telecom Software Professional Services market. Further, it includes insights provided
Global Diabetic Footwear Market Capital Outlook, Shares Analysis and Pandemic Hu …
The Diabetic Footwear Market Report is intended to function as a supportive means to assess the Diabetic Footwear market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the clients in decision-making by presenting knowledgeable data
Global AR/VR Lens Market Company Share Analysis Model by Syndicate Market Resear …
The AR/VR Lens Market Report provides an in-depth analysis of the global AR/VR Lens market, comprising the overall market synopsis, classifications, applications, definitions, and industry chain structure. The report will be offering a significant insight while shedding light on the key players [Luxexcel Group, Radiant Vision Systems LLC, Akonia Holographics (Apple), Deep Optics Ltd, Zeiss] actively participating and contributing to the growth of the global AR/VR Lens market. Further, it

All 5 Releases


More Releases for Therapeutics

Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Pontine Glioma Therapeutics- Pipeline Analysis 2018 | Y-mAbs Therapeutics, Inc.
Pontine glioma is a malignant tumour which develops from the brain stem cells. Based on the grade of growth, it is categorized into anaplastic astrocytomas and glioblastoma multiforme (GBM). Download the sample report @ https://www.pharmaproff.com/request-sample/1117 Pontine glioma is more prevalent in children than adults. The common signs and symptoms of pontine glioma are squints, swallowing problems, slurred speech, facial weakness, abnormal gait, difficulty in writing and changes in personality and behaviour.
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market. A report by Transparency Market Research uncovers after in-depth study that the global rheumatology
STORM Therapeutics Joins SMi’s 9th Annual RNA Therapeutics
SMi are delighted to welcome Oliver Rausch, VP Research & Development, Storm Therapeutics, onto the speaker line-up for day 1 at RNA Therapeutics 2018! Oliver has overall responsibility for developing STORM’s target discovery platform and for the delivery of small molecule drugs from its emerging drug discovery pipeline. Oliver worked closely with scientific founders Professors Tony Kouzarides and Eric Miska to secure the initial £12m series; an investment that launched STORM
Bone Degeneration Therapeutics Market
Bone degeneration is characterized by deterioration of articular cartilage covering the joints. Cartilage aids free movement of the joint without any resistance. Reduction in flexibility of the joint due to deterioration of cartilage leads to inflammation, compressed nerves, and pain. Aging is one of the natural causes of bone degeneration, which is also fueled by several conditions such as injuries, congenital disorders, diabetes, and obesity. Symptoms of degenerative bone disorders
Global Dyslipidemia Therapeutics Market
Dyslipidemia is one of the metabolic disorder, which is described by unbalanced level and thickness of lipoproteins and triglycerides. The disorder also includes protein deficiency and over production. These disorders can be caused by increase in the serum total cholesterol, triglyceride concentrations, and low-density lipoprotein (LDL) cholesterol, and a decrease in the high-density lipoprotein (HDL) cholesterol concentration. These condition are mainly associated with cardiovascular or coronary heart disease. The other